Understanding CLTH Complex: Potential Drug Target and Biomarker for Neurodegenerative Diseases

Target Name: CLTH complex

NCBI ID: P16817

CLTH complex

Other Name(s): None

Understanding CLTH Complex: Potential Drug Target and Biomarker for Neurodegenerative Diseases

CLTH complex, also known as Component 1 of heat shock protein (HSP) complex, is a protein that plays a crucial role in the regulation of thermal stress in cells. It is a highly conserved protein that can be found in a variety of organisms, including bacteria, archaea, and eukaryotes. CLTH complex is composed of several subunits that are arranged in a specific order to form a distinct 3D structure.

One of the key functions of CLTH complex is its ability to interact with other proteins, particularly those that are involved in stress signaling pathways. These interactions can lead to the formation of a protein-protein complex, which can in turn act as a drug target or biomarker.

CLTH complex has been identified as a potential drug target in the study of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells, and are often associated with the production of beta-amyloid peptides and other neurodegenerate hallmarks.

Research has shown that CLTH complex is involved in the regulation of the production and degradation of beta-amyloid peptides, which are thought to contribute to the development and progression of these conditions. By targeting the CLTH complex, researchers may be able to develop new treatments for neurodegenerative diseases.

Another potential application of CLTH complex as a drug target is its role in the regulation of cellular stress responses. CLTH complex is involved in the production of reactive oxygen species (ROS), which can damage cellular components and contribute to the development of oxidative stress- induced diseases. By targeting the CLTH complex, researchers may be able to develop new treatments for a variety of conditions, including cancer, aging, and neurodegenerative diseases.

In addition to its potential as a drug target, CLTH complex has also been identified as a potential biomarker for a variety of diseases. The regulation of CLTH complex has been shown to be involved in the development and progression of a number of diseases, including neurodegenerative conditions, cancer, and aging. By measuring the levels of CLTH complex in cells or tissues, researchers may be able to diagnose or predict the outcome of these conditions.

CLTH complex has also been shown to be involved in a variety of cellular processes that are important for cell survival. For example, CLTH complex is involved in the regulation of the production of cellular membrane, which is the boundary between cells and the surrounding environment. It is also involved in the regulation of the production and degradation of other cellular components, including cytoskeletal filaments and vesicles.

In conclusion, CLTH complex is a protein that plays a crucial role in the regulation of thermal stress in cells. Its interaction with other proteins and its ability to participate in a variety of cellular processes make it an attractive target for research and development of new treatments for a variety of diseases. Further research is needed to fully understand the role of CLTH complex in cellular processes and its potential as a drug or biomarker.

Protein Name: CLTH Complex

The "CLTH complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CLTH complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets